The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Purpose
To describe the outcome of switching from ranibizumab to aflibercept intravitreal injections in patients with macular oedema secondary to central retinal vein occlusion (CRVO).
Methods
A prospective observational study was conducted in a tertiary retina service in East Midlands, UK. Twenty one patients with CRVO and associated macular oedema were reviewed. All patients had a detailed systemic...
Purpose To present the our initial clinical outcomes of dexamethasone 0.7mg intravitreal implant (Ozurdex®) in the first three months after the injection.
Methods Seventeen patients (12 male and 5 female, mean age 64.9y) diagnosed with retinal vein occlusions (RVO) and cystoid macular oedema (CMO) received an Ozurdex injection after baseline best corrected visual acuity (BCVA) and central retinal...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.